Hot Topics in Public Health
Public Health News
-
What Wins The Physician Community Got in the HORA Revision BillMay 8, 2024
Working together across specialties, the bill to update DC health licensing and regulation had some major improvements amidst some concerning changes
Continue Reading -
MSDC Sends Sign-On Letter Opposing Scope ChangesMay 2, 2024
The letter, signed by numerous DC physicians, reiterates the physician community's concern with legislation updating the HORA.
Continue Reading -
MSDC Raises Scope Creep and More with DC Board of MedicineApril 24, 2024
MSDC staff visited the Board's meeting to discuss further collaboration and share opinions on important health issues.
Continue Reading -
What to Know About the DC Scope of Practice Expansion BillApril 9, 2024
Physicians need to act now to stop scope expansion in DC. We tell you how.
Continue Reading -
MSDC Announces New Partnership with ACLMMarch 26, 2024
MSDC members can support their Foundation and education at the same time, while learning more about lifestyle medicine.
Continue Reading -
MSDC President Dr. Ashesh Patel's Statement on Markup of B25-545March 21, 2024
MSDC remains concerned about the bill's scope of practice expansions but thanks the committee members and staff for their work on the bill.
Continue Reading -
MSDC’s 2024 Capital Healthcare Honors Breaks Records and Recognizes ExcellenceMarch 20, 2024
The medical community came together to celebrate the awardees and show the best of DC medicine.
Continue Reading -
March 11 UPDATE on Change Healthcare Cybersecurity IssueMarch 6, 2024
Share your feedback with the key players in the cybersecurity incident,
Continue Reading -
MSDC to DHCF: Fund Prior AuthorizationFebruary 9, 2024
MSDC urged the Council to address the disparity between private and Medicaid insureds in regards to the District's prior auth law.
Continue Reading -
DHCF: Notification of Policy Change-Physician Administered Drug Reimbursement RatesJanuary 26, 2024
The purpose of this transmittal is to notify DC Medicaid Providers of a policy change regarding reimbursement rates for physician-administered drugs under the "Buy & Bill" policy.
Continue Reading